JP2024544870A5 - - Google Patents
Info
- Publication number
- JP2024544870A5 JP2024544870A5 JP2024527096A JP2024527096A JP2024544870A5 JP 2024544870 A5 JP2024544870 A5 JP 2024544870A5 JP 2024527096 A JP2024527096 A JP 2024527096A JP 2024527096 A JP2024527096 A JP 2024527096A JP 2024544870 A5 JP2024544870 A5 JP 2024544870A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111329108.1 | 2021-11-10 | ||
| CN202111329108 | 2021-11-10 | ||
| PCT/CN2022/130833 WO2023083209A1 (zh) | 2021-11-10 | 2022-11-09 | 一种靶向psma抗原的配体化合物及其螯合物与用于前列腺癌诊断和治疗的应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024544870A JP2024544870A (ja) | 2024-12-05 |
| JP2024544870A5 true JP2024544870A5 (https=) | 2025-12-12 |
| JPWO2023083209A5 JPWO2023083209A5 (https=) | 2025-12-12 |
Family
ID=86335105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024527096A Pending JP2024544870A (ja) | 2021-11-10 | 2022-11-09 | Ｐｓｍａ抗原を標的とするリガンド化合物及びそのキレート並びに前立腺癌の診断及び治療のための応用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20260069725A1 (https=) |
| EP (1) | EP4431503A1 (https=) |
| JP (1) | JP2024544870A (https=) |
| KR (1) | KR20240105380A (https=) |
| CN (1) | CN118176188A (https=) |
| AU (1) | AU2022384375A1 (https=) |
| CA (1) | CA3237743A1 (https=) |
| TW (1) | TW202321204A (https=) |
| WO (1) | WO2023083209A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118852044A (zh) | 2021-09-03 | 2024-10-29 | 晶核生物医药科技(南京)有限公司 | 一种肽脲素衍生物、含其的药物组合物及其应用 |
| CN117069670B (zh) * | 2023-07-31 | 2026-04-10 | 复旦大学附属华山医院 | 靶向psma的二聚体化合物及其衍生物和应用 |
| CN119954773A (zh) * | 2023-10-31 | 2025-05-09 | 苏州威智创科生物有限公司 | Psma化合物、包含其的药物组合物及其用途 |
| WO2025167998A1 (zh) * | 2024-02-06 | 2025-08-14 | 北京昌平实验室 | 膦酸酯骨架的psma靶向偶联物 |
| CN118221764A (zh) * | 2024-03-05 | 2024-06-21 | 苏州大学 | 一种双靶向分子探针及其制备方法与应用 |
| WO2026002208A1 (zh) * | 2024-06-28 | 2026-01-02 | 思路迪生物医药(上海)有限公司 | 前列腺特异性膜抗原小分子抑制剂及其放射性核素配合物的制备及应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11629201B2 (en) * | 2017-05-24 | 2023-04-18 | ITM Isotope Technologies Munich SE | PSMA-binding agents and uses thereof |
| US20200339625A1 (en) * | 2017-10-22 | 2020-10-29 | Provincial Health Services Authority | Novel radiometal-binding compounds for diagnosis or treatment of prostate specific membrane antigen-expressing cancer |
| CN114401947B (zh) * | 2019-06-21 | 2024-11-29 | 省卫生服务机构 | 靶向前列腺特异性膜抗原的放射性标记化合物 |
-
2022
- 2022-11-09 JP JP2024527096A patent/JP2024544870A/ja active Pending
- 2022-11-09 CA CA3237743A patent/CA3237743A1/en active Pending
- 2022-11-09 TW TW111142867A patent/TW202321204A/zh unknown
- 2022-11-09 US US18/708,905 patent/US20260069725A1/en active Pending
- 2022-11-09 AU AU2022384375A patent/AU2022384375A1/en active Pending
- 2022-11-09 CN CN202280074508.9A patent/CN118176188A/zh active Pending
- 2022-11-09 EP EP22892003.9A patent/EP4431503A1/en active Pending
- 2022-11-09 KR KR1020247014634A patent/KR20240105380A/ko active Pending
- 2022-11-09 WO PCT/CN2022/130833 patent/WO2023083209A1/zh not_active Ceased